Cargando…

Effect of Low-Dose, Long-Term Roxithromycin on Airway Inflammation and Remodeling of Stable Noncystic Fibrosis Bronchiectasis

Background. Noncystic fibrosis bronchiectasis (NCFB) is characterized by airway expansion and recurrent acute exacerbations. Macrolide has been shown to exhibit anti-inflammatory effects in some chronic airway diseases. Objective. To assess the efficacy of roxithromycin on airway inflammation and re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jifeng, Zhong, Xiaoning, He, Zhiyi, Wei, Lianghong, Zheng, Xiaozhen, Zhang, Jianquan, Bai, Jing, Zhong, Wei, Zhong, Dengjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235134/ https://www.ncbi.nlm.nih.gov/pubmed/25580060 http://dx.doi.org/10.1155/2014/708608

Ejemplares similares

The Role of Macrolides in Noncystic Fibrosis Bronchiectasis
por: Figueiredo, Bruna de Campos Guimarães e, et al.
Publicado: (2011)

Noncystic fibrosis bronchiectasis: Is it an orphan disease?
por: Mobaireek, Khalid F.
Publicado: (2007)

Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis
por: Bonaiti, Giulia, et al.
Publicado: (2015)

Gastro-Oesophageal Reflux in Noncystic Fibrosis Bronchiectasis
por: Lee, Annemarie L., et al.
Publicado: (2011)

A neglected problem of developing countries: Noncystic fibrosis bronchiectasis
por: Babayigit, Arzu, et al.
Publicado: (2009)

Quality of life and its determinants in patients with noncystic fibrosis bronchiectasis
por: Sami, Ramin, et al.
Publicado: (2021)

Infection prevention and chronic disease management in cystic fibrosis and noncystic fibrosis bronchiectasis
por: Lommatzsch, Sherstin T.
Publicado: (2020)

Risk Factors Associated with Impairment in Pulmonary Diffusing Capacity among Patients with Noncystic Fibrosis Bronchiectasis
por: Zhang, Kaijun, et al.
Publicado: (2022)

Noninvasive Ventilation for Acute Respiratory Failure due to Noncystic Fibrosis Bronchiectasis
por: Hadda, Vijay, et al.
Publicado: (2018)

Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013
por: Weycker, Derek, et al.
Publicado: (2017)

Nebulized hypertonic saline in noncystic fibrosis bronchiectasis: a comprehensive review
por: Máiz Carro, Luis, et al.
Publicado: (2019)

The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis
por: Al-Jahdali, Hamdan, et al.
Publicado: (2017)

Neutrophilic Bronchial Inflammation Correlates with Clinical and Functional Findings in Patients with Noncystic Fibrosis Bronchiectasis
por: Dente, Federico L., et al.
Publicado: (2015)

Development of Inhalable Nanostructured Lipid Carriers for Ciprofloxacin for Noncystic Fibrosis Bronchiectasis Treatment
por: Almurshedi, Alanood S, et al.
Publicado: (2021)

Total oxidant and antioxidant status and paraoxonase 1 levels ofchildren with noncystic fibrosis bronchiectasis
por: GEDİK, Ahmet Hakan, et al.
Publicado: (2020)

Pulmonary Bacterial Communities in Surgically Resected Noncystic Fibrosis Bronchiectasis Lungs Are Similar to Those in Cystic Fibrosis
por: Maughan, Heather, et al.
Publicado: (2012)

A review of 151 cases of pediatric noncystic fibrosis bronchiectasis in a tertiary care center
por: Banjar, Hanaa Hasan
Publicado: (2007)

Meta-analysis of macrolide maintenance therapy for prevention of disease exacerbations in patients with noncystic fibrosis bronchiectasis
por: Wang, Donghai, et al.
Publicado: (2019)

Which scoring system is better in association with exercise capacity and health status in noncystic fibrosis bronchiectasis patients?
por: VAROL, Yelda, et al.
Publicado: (2021)

Distribution of Major Pathogens from Sputum and Bronchoalveolar Lavage Fluid in Patients with Noncystic Fibrosis Bronchiectasis: A Systematic Review
por: Miao, Xia-Yi, et al.
Publicado: (2015)

Effects of exercise on secretion transport, inflammation, and quality of life in patients with noncystic fibrosis bronchiectasis: Protocol for a randomized controlled trial
por: dos Santos, Daniele Oliveira, et al.
Publicado: (2018)

Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study
por: Wei, Ping, et al.
Publicado: (2016)

The Impact of Cystic Fibrosis- and Noncystic Fibrosis-Bronchiectasis on Pulmonary Artery Wall Thickness and Right Heart Functions Assessed by Speckle-Tracking Echocardiography
por: Gürel, Emre, et al.
Publicado: (2023)

A retrospective correlative profiling of lung functions, microbiological, radiological, periodontal, hematological parameters in noncystic fibrosis bronchiectasis patients of North India
por: Gupta, Abhaya, et al.
Publicado: (2022)

Roxithromycin-Associated Acute Thrombocytopenia
por: Rossi, Marco, et al.
Publicado: (2021)

Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study: Notice of Retraction
Publicado: (2017)

Identification of key genes in human airway epithelial cells in response to respiratory pathogens using microarray analysis
por: Li, Yinghua, et al.
Publicado: (2018)

Effects of Low-Dose and Long-Term Treatment with Erythromycin on Interleukin-17 and Interleukin-23 in Peripheral Blood and Induced Sputum in Patients with Stable Chronic Obstructive Pulmonary Disease
por: Tan, Caimei, et al.
Publicado: (2016)

Aberrant Epithelial Cell Proliferation in Peripheral Airways in Bronchiectasis
por: Peng, Yang, et al.
Publicado: (2020)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021)

Adrenal insufficiency in patients with stable non-cystic fibrosis bronchiectasis
por: Rajagopala, Srinivas, et al.
Publicado: (2014)

Erythromycin Suppresses the Cigarette Smoke Extract-Exposed Dendritic Cell-Mediated Polarization of CD4(+) T Cells into Th17 Cells
por: Liu, Jifeng, et al.
Publicado: (2020)

Non-antimicrobial airway management of non-cystic fibrosis bronchiectasis
por: Egan, Ashley M., et al.
Publicado: (2017)

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Bergin, David A, et al.
Publicado: (2013)

Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study
por: Svanström, Henrik, et al.
Publicado: (2014)

Effect of obstructive airway disease in patients with non-cystic fibrosis bronchiectasis
por: Khalid, Mohammed, et al.
Publicado: (2004)

A longitudinal characterization of the Non-Cystic Fibrosis Bronchiectasis airway microbiome
por: Woo, T. E., et al.
Publicado: (2019)

Roxithromycin attenuates inflammation via modulation of RAGE-influenced calprotectin expression in a neutrophilic asthma model
por: Gu, Xiaofei, et al.
Publicado: (2021)

Diagnosis of bronchiectasis and airway wall thickening in children with cystic fibrosis: Objective airway-artery quantification
por: Kuo, Wieying, et al.
Publicado: (2017)

Noncystic cerebellopontine angle hemangioblastoma: A case of an atypical location
por: Pamela Ferreira Neto, Barbara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pr2cpnt8ahsk61iks17g0gn4qv